Non-invasive light stimulation to improve attention in adults
Official title: Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
Run by University of Texas at Austin · NCT05802680 · Data updated 2026-11-12
This study is testing if a non-invasive light treatment can help improve attention in adults, including those with ADHD.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | University of Texas at Austin Academic / other |
| Locations | 1 site (Austin, Texas) |
| Status | Recruiting |
| Started | February 9, 2022 |
| Main results expected | December 31, 2026 |
| Study ends | February 1, 2027 |
| Registry record updated | June 22, 2026 |
| Trial ID | NCT05802680 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 years and older, including those diagnosed with ADHD.
✕Probably not a fit
Patients with significant neurological disorders or those who do not meet the age requirement may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of transcranial photobiomodulation (tPBM) on attention in adults, including those with Attention Deficit Hyperactivity Disorder (ADHD). Participants will be screened for eligibility using the Adult ADHD Self-Report Scale and will be randomly assigned to receive either active tPBM or a sham treatment. The goal is to determine if tPBM can enhance cognitive function and attention in both healthy adults and those with ADHD. The intervention lasts for eight minutes and aims to assess improvements in sustained attention.
Why it matters
Potential benefit: If successful, this approach could provide a new non-invasive treatment option for improving attention in individuals with ADHD and related cognitive deficits.
How similar studies have gone: While the use of tPBM has shown promise in enhancing cognitive function in healthy adults, its specific effects on attention in ADHD have not been previously studied, making this a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older Exclusion Criteria: * None
Where it's running
-
The University of Texas at Austin
Austin, Texas, United States Recruiting
Study contacts
- Study coordinator: Francisco Gonzalez-Lima, PhD
- Email: UTADHDExperiment@gmail.com
- Phone: (512) 475-8497
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
The GLOW Program: GLP-1 and Lifestyle for Wellness
This study tests whether a 30-day WILD 5 Wellness lifestyle program can improve physical and emotional well-being in adults already taking a GLP-1 or GLP-1/GIP medication.
-
See if cognitive impairment is common in older adults admitted for non-neurological rehab
This study tests how often cognitive impairment appears in patients aged 45 and older who are in non-neurological rehab units after hospitalization.
-
Foquest in older adults with ADHD: daily methylphenidate for 65+
This study tests whether once-daily Foquest helps symptoms in adults 65 and older with ADHD.
-
Neuroplasticity-targeted supplements for ADHD in children
A 12-week randomized trial tests whether gut- and brain-targeted supplements can help reduce ADHD symptoms in children aged 6–12.
-
Therapy approaches for irritability in youths: active treatments vs nonactive psychoeducation
This study tests whether active psychotherapies for irritability in kids aged 8–16.5 years work better than nonactive, time-matched psychoeducation for children and their parents.
-
Playful physiotherapy to support children with ADHD or autism
This program will try a play-based physiotherapy approach to see if it improves emotional, behavioral, and social functioning in Estonian-speaking children aged 5–12 with ADHD or autism.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.